EVIDENCE THAT VENLAFAXINE DOES NOT INHIBIT CYP1A2 AS MEASURED IN-VIVOBY THE METABOLISM OF CAFFEINE

Authors
AMCHIN J ZARYCRANSKI W TAYLOR K
Citation
J. Amchin et al., EVIDENCE THAT VENLAFAXINE DOES NOT INHIBIT CYP1A2 AS MEASURED IN-VIVOBY THE METABOLISM OF CAFFEINE, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 57-57
Citations number
NO
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
Clinical pharmacology and therapeutics → ACNP
ISSN journal
00099236
Volume
61
Issue
2
Year of publication
1997
Pages
57 - 57
Database
ISI
SICI code
0009-9236(1997)61:2<57:ETVDNI>2.0.ZU;2-K